Oncology Companion Diagnostic Market, Global Outlook and Forecast 2024-2031

Report ID: 1066764 | Published Date: Jan 2025 | No. of Page: 65 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Oncology Companion Diagnostic Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Oncology Companion Diagnostic Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Oncology Companion Diagnostic Overall Market Size
    2.1 Global Oncology Companion Diagnostic Market Size: 2021 VS 2028
    2.2 Global Oncology Companion Diagnostic Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Oncology Companion Diagnostic Players in Global Market
    3.2 Top Global Oncology Companion Diagnostic Companies Ranked by Revenue
    3.3 Global Oncology Companion Diagnostic Revenue by Companies
    3.4 Top 3 and Top 5 Oncology Companion Diagnostic Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Oncology Companion Diagnostic Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Oncology Companion Diagnostic Players in Global Market
        3.6.1 List of Global Tier 1 Oncology Companion Diagnostic Companies
        3.6.2 List of Global Tier 2 and Tier 3 Oncology Companion Diagnostic Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Oncology Companion Diagnostic Market Size Markets, 2021 & 2028
        4.1.2 Polymerase Chain Reaction (PCR)
        4.1.3 Next-Generation Sequencing (NGS)
        4.1.4 Immunohistochemistry (IHC)
        4.1.5 In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
        4.1.6 Others
    4.2 By Type - Global Oncology Companion Diagnostic Revenue & Forecasts
        4.2.1 By Type - Global Oncology Companion Diagnostic Revenue, 2017-2022
        4.2.2 By Type - Global Oncology Companion Diagnostic Revenue, 2023-2028
        4.2.3 By Type - Global Oncology Companion Diagnostic Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Oncology Companion Diagnostic Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Pathology/Diagnostic Laboratory
        5.1.4 Academic Medical Center
    5.2 By Application - Global Oncology Companion Diagnostic Revenue & Forecasts
        5.2.1 By Application - Global Oncology Companion Diagnostic Revenue, 2017-2022
        5.2.2 By Application - Global Oncology Companion Diagnostic Revenue, 2023-2028
        5.2.3 By Application - Global Oncology Companion Diagnostic Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Oncology Companion Diagnostic Market Size, 2021 & 2028
    6.2 By Region - Global Oncology Companion Diagnostic Revenue & Forecasts
        6.2.1 By Region - Global Oncology Companion Diagnostic Revenue, 2017-2022
        6.2.2 By Region - Global Oncology Companion Diagnostic Revenue, 2023-2028
        6.2.3 By Region - Global Oncology Companion Diagnostic Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Oncology Companion Diagnostic Revenue, 2017-2028
        6.3.2 US Oncology Companion Diagnostic Market Size, 2017-2028
        6.3.3 Canada Oncology Companion Diagnostic Market Size, 2017-2028
        6.3.4 Mexico Oncology Companion Diagnostic Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Oncology Companion Diagnostic Revenue, 2017-2028
        6.4.2 Germany Oncology Companion Diagnostic Market Size, 2017-2028
        6.4.3 France Oncology Companion Diagnostic Market Size, 2017-2028
        6.4.4 U.K. Oncology Companion Diagnostic Market Size, 2017-2028
        6.4.5 Italy Oncology Companion Diagnostic Market Size, 2017-2028
        6.4.6 Russia Oncology Companion Diagnostic Market Size, 2017-2028
        6.4.7 Nordic Countries Oncology Companion Diagnostic Market Size, 2017-2028
        6.4.8 Benelux Oncology Companion Diagnostic Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Oncology Companion Diagnostic Revenue, 2017-2028
        6.5.2 China Oncology Companion Diagnostic Market Size, 2017-2028
        6.5.3 Japan Oncology Companion Diagnostic Market Size, 2017-2028
        6.5.4 South Korea Oncology Companion Diagnostic Market Size, 2017-2028
        6.5.5 Southeast Asia Oncology Companion Diagnostic Market Size, 2017-2028
        6.5.6 India Oncology Companion Diagnostic Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Oncology Companion Diagnostic Revenue, 2017-2028
        6.6.2 Brazil Oncology Companion Diagnostic Market Size, 2017-2028
        6.6.3 Argentina Oncology Companion Diagnostic Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Oncology Companion Diagnostic Revenue, 2017-2028
        6.7.2 Turkey Oncology Companion Diagnostic Market Size, 2017-2028
        6.7.3 Israel Oncology Companion Diagnostic Market Size, 2017-2028
        6.7.4 Saudi Arabia Oncology Companion Diagnostic Market Size, 2017-2028
        6.7.5 UAE Oncology Companion Diagnostic Market Size, 2017-2028
7 Players Profiles
    7.1 Agilent Technologies, Inc.
        7.1.1 Agilent Technologies, Inc. Corporate Summary
        7.1.2 Agilent Technologies, Inc. Business Overview
        7.1.3 Agilent Technologies, Inc. Oncology Companion Diagnostic Major Product Offerings
        7.1.4 Agilent Technologies, Inc. Oncology Companion Diagnostic Revenue in Global Market (2017-2022)
        7.1.5 Agilent Technologies, Inc. Key News
    7.2 Illumina, Inc.
        7.2.1 Illumina, Inc. Corporate Summary
        7.2.2 Illumina, Inc. Business Overview
        7.2.3 Illumina, Inc. Oncology Companion Diagnostic Major Product Offerings
        7.2.4 Illumina, Inc. Oncology Companion Diagnostic Revenue in Global Market (2017-2022)
        7.2.5 Illumina, Inc. Key News
    7.3 Qiagen N.V.
        7.3.1 Qiagen N.V. Corporate Summary
        7.3.2 Qiagen N.V. Business Overview
        7.3.3 Qiagen N.V. Oncology Companion Diagnostic Major Product Offerings
        7.3.4 Qiagen N.V. Oncology Companion Diagnostic Revenue in Global Market (2017-2022)
        7.3.5 Qiagen N.V. Key News
    7.4 Thermo Fisher Scientific Inc.
        7.4.1 Thermo Fisher Scientific Inc. Corporate Summary
        7.4.2 Thermo Fisher Scientific Inc. Business Overview
        7.4.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Major Product Offerings
        7.4.4 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Revenue in Global Market (2017-2022)
        7.4.5 Thermo Fisher Scientific Inc. Key News
    7.5 F. Hoffmann-La Roche Ltd.
        7.5.1 F. Hoffmann-La Roche Ltd. Corporate Summary
        7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
        7.5.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Major Product Offerings
        7.5.4 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Revenue in Global Market (2017-2022)
        7.5.5 F. Hoffmann-La Roche Ltd. Key News
    7.6 ARUP Laboratories
        7.6.1 ARUP Laboratories Corporate Summary
        7.6.2 ARUP Laboratories Business Overview
        7.6.3 ARUP Laboratories Oncology Companion Diagnostic Major Product Offerings
        7.6.4 ARUP Laboratories Oncology Companion Diagnostic Revenue in Global Market (2017-2022)
        7.6.5 ARUP Laboratories Key News
    7.7 Abbott
        7.7.1 Abbott Corporate Summary
        7.7.2 Abbott Business Overview
        7.7.3 Abbott Oncology Companion Diagnostic Major Product Offerings
        7.7.4 Abbott Oncology Companion Diagnostic Revenue in Global Market (2017-2022)
        7.7.5 Abbott Key News
    7.8 Myriad Genetics, Inc.
        7.8.1 Myriad Genetics, Inc. Corporate Summary
        7.8.2 Myriad Genetics, Inc. Business Overview
        7.8.3 Myriad Genetics, Inc. Oncology Companion Diagnostic Major Product Offerings
        7.8.4 Myriad Genetics, Inc. Oncology Companion Diagnostic Revenue in Global Market (2017-2022)
        7.8.5 Myriad Genetics, Inc. Key News
    7.9 bioMérieux SA
        7.9.1 bioMérieux SA Corporate Summary
        7.9.2 bioMérieux SA Business Overview
        7.9.3 bioMérieux SA Oncology Companion Diagnostic Major Product Offerings
        7.9.4 bioMérieux SA Oncology Companion Diagnostic Revenue in Global Market (2017-2022)
        7.9.5 bioMérieux SA Key News
    7.10 Invivoscribe, Inc.
        7.10.1 Invivoscribe, Inc. Corporate Summary
        7.10.2 Invivoscribe, Inc. Business Overview
        7.10.3 Invivoscribe, Inc. Oncology Companion Diagnostic Major Product Offerings
        7.10.4 Invivoscribe, Inc. Oncology Companion Diagnostic Revenue in Global Market (2017-2022)
        7.10.5 Invivoscribe, Inc. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Oncology Companion Diagnostic Market Opportunities & Trends in Global Market
    Table 2. Oncology Companion Diagnostic Market Drivers in Global Market
    Table 3. Oncology Companion Diagnostic Market Restraints in Global Market
    Table 4. Key Players of Oncology Companion Diagnostic in Global Market
    Table 5. Top Oncology Companion Diagnostic Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Oncology Companion Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Oncology Companion Diagnostic Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Oncology Companion Diagnostic Product Type
    Table 9. List of Global Tier 1 Oncology Companion Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Oncology Companion Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Oncology Companion Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Oncology Companion Diagnostic Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Oncology Companion Diagnostic Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Oncology Companion Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Oncology Companion Diagnostic Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Oncology Companion Diagnostic Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Oncology Companion Diagnostic Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Oncology Companion Diagnostic Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Oncology Companion Diagnostic Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Oncology Companion Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Oncology Companion Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Oncology Companion Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Oncology Companion Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Oncology Companion Diagnostic Revenue, (US$, Mn), 2023-2028
    Table 30. Agilent Technologies, Inc. Corporate Summary
    Table 31. Agilent Technologies, Inc. Oncology Companion Diagnostic Product Offerings
    Table 32. Agilent Technologies, Inc. Oncology Companion Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 33. Illumina, Inc. Corporate Summary
    Table 34. Illumina, Inc. Oncology Companion Diagnostic Product Offerings
    Table 35. Illumina, Inc. Oncology Companion Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 36. Qiagen N.V. Corporate Summary
    Table 37. Qiagen N.V. Oncology Companion Diagnostic Product Offerings
    Table 38. Qiagen N.V. Oncology Companion Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 39. Thermo Fisher Scientific Inc. Corporate Summary
    Table 40. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Offerings
    Table 41. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 42. F. Hoffmann-La Roche Ltd. Corporate Summary
    Table 43. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Offerings
    Table 44. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 45. ARUP Laboratories Corporate Summary
    Table 46. ARUP Laboratories Oncology Companion Diagnostic Product Offerings
    Table 47. ARUP Laboratories Oncology Companion Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 48. Abbott Corporate Summary
    Table 49. Abbott Oncology Companion Diagnostic Product Offerings
    Table 50. Abbott Oncology Companion Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 51. Myriad Genetics, Inc. Corporate Summary
    Table 52. Myriad Genetics, Inc. Oncology Companion Diagnostic Product Offerings
    Table 53. Myriad Genetics, Inc. Oncology Companion Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 54. bioMérieux SA Corporate Summary
    Table 55. bioMérieux SA Oncology Companion Diagnostic Product Offerings
    Table 56. bioMérieux SA Oncology Companion Diagnostic Revenue (US$, Mn), (2017-2022)
    Table 57. Invivoscribe, Inc. Corporate Summary
    Table 58. Invivoscribe, Inc. Oncology Companion Diagnostic Product Offerings
    Table 59. Invivoscribe, Inc. Oncology Companion Diagnostic Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Oncology Companion Diagnostic Segment by Type in 2021
    Figure 2. Oncology Companion Diagnostic Segment by Application in 2021
    Figure 3. Global Oncology Companion Diagnostic Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Oncology Companion Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Oncology Companion Diagnostic Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Oncology Companion Diagnostic Revenue in 2021
    Figure 8. By Type - Global Oncology Companion Diagnostic Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Oncology Companion Diagnostic Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Oncology Companion Diagnostic Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Oncology Companion Diagnostic Revenue Market Share, 2017-2028
    Figure 12. US Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Oncology Companion Diagnostic Revenue Market Share, 2017-2028
    Figure 16. Germany Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 17. France Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Oncology Companion Diagnostic Revenue Market Share, 2017-2028
    Figure 24. China Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 28. India Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Oncology Companion Diagnostic Revenue Market Share, 2017-2028
    Figure 30. Brazil Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Oncology Companion Diagnostic Revenue Market Share, 2017-2028
    Figure 33. Turkey Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Oncology Companion Diagnostic Revenue, (US$, Mn), 2017-2028
    Figure 37. Agilent Technologies, Inc. Oncology Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Illumina, Inc. Oncology Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Qiagen N.V. Oncology Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. ARUP Laboratories Oncology Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Abbott Oncology Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Myriad Genetics, Inc. Oncology Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. bioMérieux SA Oncology Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Invivoscribe, Inc. Oncology Companion Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
65
Frequently Asked Questions
Oncology Companion Diagnostic Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncology Companion Diagnostic Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncology Companion Diagnostic Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports